Research

Revolutionary Discovery for Drug Development

“The company was made possible with technology developed at UNC…”

“The company was made possible with technology developed at UNC…”

Today, the majority of drugs and pharmaceuticals on the market that treat human disease are designed to target a specific protein. But University of North Carolina at Chapel Hill startup, RibometrixOpens in new window,has a very different, revolutionary approach to new drug discovery that’s proving to be a breakthrough in the industry.

Ribometrix’s novel approach has the potential to improve millions of lives by offering new treatments for a range of diseases, ranging from cancer, neurological disorders, immunological diseases, and rare diseases such as Huntington’s Disease.

“The company was made possible with technology developed at UNC, with support from the UNC ecosystem. The initial ideas and innovation came from the academic side, but we were able to transfer this knowledge into something tangible and entrepreneurial for the greater good,” said Katie Warner, co-founder and director of research at Ribometrix.

Read the complete Carolina Story from Innovate Carolina…Opens in new window

Innovate Carolina Funding Priorities

    Readers Also Viewed...

    Entrepreneurial faculty members
    Faculty Support

    Where Faculty Startups Start Out

    New space on campus will provide faculty with a collaborative place to grow their companies

    Data analyst at computer
    Innovation

    Data-Driven Confidence

    New digital tool that offers county-level insight and answers

    Chad Pecot in the lab
    Innovation

    Muting Genetic Mutations

    Cancer survivor kickstarts research for a cure